Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. by Nurmikko, P, Pettersson, K, Piironen, T, Hugosson, J, Lilja, H

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA. by Nurmikko, P, Väisänen, V, Piironen, T, Lindgren, S, Lilja, H, Pettersson, K

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146 by Nurmikko, P, Steuber, T, Haese, A, Pettersson, K, Hammerer, P, Huland, H, Lilja, H

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen. by Steuber, T, Nurmikko, P, Haese, A, Pettersson, K, Graefen, M, Hammerer, P, Huland, H, Lilja, H